Bio Rad Laboratories, Inc. - Feb 10, 2025 SCHEDULE 13G/A Report for Oncocyte Corporation Common Shares, No Par Value (OCX)

Filing Manager: Bio Rad Laboratories, Inc.
Reporting Manager: BIO-RAD LABORATORIES, INC
Security: Oncocyte Corporation Common Shares, No Par Value
Symbol: OCX
Shares outstanding: 28.5M shares
Disclosed Ownership: 2.76M shares
Ownership: 9.7%
Form type: SCHEDULE 13G/A
Date filed: 3/4/2025, 07:06 PM
Date of event: Feb 10, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BIO-RAD LABORATORIES, INC	9.7%	2.76M	2.76M	0	/s/ Courtney C. Enloe	Courtney C. Enloe/Executive Vice President, General Counsel and Secretary